Secondary prevention after cerebral ischaemia of presumed arterial origin: Is aspirin still the touchstone?

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 5, 1999, Pages 557-559

  Algra, A ^a   Van Gijn, J ^a   Koudstaal, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR; TICLOPIDINE;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GINGIVA BLEEDING; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SECONDARY PREVENTION; STROKE;

EID: 0032942987     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.5.557     Document Type: Editorial

References (22)